Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway
Our study suggests that avermectin B1 is a potential agent to treat osteosarcoma cells through the AMPK/ULK1 signaling pathway.
Authors
- Qingcheng Yang (ORCID: https://orcid.org/0000-0002-6600-5467)
- Chen Tan (ORCID: https://orcid.org/0000-0003-4622-4483)
- Dongdong Cheng (ORCID: https://orcid.org/0000-0002-4411-9949)
- Zhaohui Li (ORCID: https://orcid.org/0000-0002-4132-658X)
- Xiang Fei (ORCID: https://orcid.org/0009-0004-3773-550X)
- Zhen Pan (ORCID: https://orcid.org/0009-0006-1940-7240)
- Yonghui Liang (ORCID: https://orcid.org/0009-0003-7126-1822)
Institutions
- Renji Hospital (CN)
- Tongren Hospital (CN)
Publication Details
- Journal
- Cancer Chemotherapy and Pharmacology
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1007/s00280-024-04695-z
- Citations
- 2
- Primary Topic
- Parasites and Host Interactions
- Type
- article
- Field-Weighted Citation Impact
- 1.03
Funders
- National Natural Science Foundation of China